TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 14:56:23 GMT 2023` Edited by `admin` on `Sat Dec 16 14:56:23 GMT 2023`
Protein Type	RECEPTOR
Protein Sub Type	CYTOKINE RECEPTOR
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	CA9PO31PIJ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5

Common Name

English

TNFRSF5

Common Name

English

CDW40

Common Name

English

CD40

Common Name

English

B-CELL SURFACE ANTIGEN CD40

Common Name

English

CD40L RECEPTOR

Common Name

English

BP50

Common Name

English

Code System Code Type Description

PHAROS

P25942

Created by admin on Sat Dec 16 14:56:24 GMT 2023 , Edited by admin on Sat Dec 16 14:56:24 GMT 2023

PRIMARY

UNIPROT

P25942

Created by admin on Sat Dec 16 14:56:24 GMT 2023 , Edited by admin on Sat Dec 16 14:56:24 GMT 2023

PRIMARY

FDA UNII

CA9PO31PIJ

Created by admin on Sat Dec 16 14:56:24 GMT 2023 , Edited by admin on Sat Dec 16 14:56:24 GMT 2023

PRIMARY

From	To
1_6	1_17
1_18	1_31
1_21	1_39
1_42	1_57
1_63	1_83
1_85	1_99
1_91	1_96
1_105	1_123

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_133
N	1_160

Related Record Type Details


					G0MV33WQ6V

TENELIXIMAB

INHIBITOR -> TARGET


					UT59FF4T5X

DACETUZUMAB

LIGAND->TARGET


					0O39RGI33V

SELICRELUMAB

AGONIST -> TARGET

Amount:


					G2CB897733

YH-003

AGONIST -> TARGET

Amount:


					27X2015N23

TECAGINLIMAB

ACTIVATOR -> TARGET


					OWK8BG0FO6

CDX-1140

AGONIST -> TARGET

Amount:


					JEA93WJ5DG

SOTIGALIMAB

AGONIST -> TARGET

Comments:

Agonist of the cell surface receptor CD40, with potential immunostimulatory and antineoplastic activities.

Interaction Type:

AGONIST

Amount:


					Q9J81E7VFM

MITAZALIMAB

AGONIST -> TARGET

Amount:


					AS3AZ5R46K

BLESELUMAB

INHIBITOR -> TARGET


					0628T707D0

ISCALIMAB

INHIBITOR -> TARGET


					TIN30KQI3W

Abiprubart

INHIBITOR -> TARGET

Amount:


					P0EP9VFC4R

LUCATUMUMAB

INHIBITOR -> TARGET

Interaction Type:

BINDING


					W6C58X3BFH

GILORALIMAB

AGONIST -> TARGET


					IF0TRZ2MZ3

MEDI-5083

AGONIST -> TARGET


					YGF9TW3QZJ

RAVAGALIMAB

INHIBITOR -> TARGET

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL